Penn Heart & Vascular

@PennCardiology

Account inactive as of 5/31/26 • Providing high-quality care, advancing research, and training future heart & vascular specialists.

Pennsylvania, USA pennmedicine.org/physician-reso… Joined April 2019

637 Following 3K Followers 1.7K Posts

Latest posts 5

Penn Heart & Vascular @PennCardiology May 30

Beginning tomorrow, the @PennCardiology X account will no longer be active.

Follow @PennMedicine and @PennMDForum for cardiology/cardiac surgery news and updates.

Penn Heart & Vascular @PennCardiology May 26

The @PennCardiology X account will be inactive as of May 31st.

For cardiology and cardiac surgery news, follow @PennMedicine and @PennMDForum.

Penn Heart & Vascular @PennCardiology May 21

This account will be sunset on Sunday, May 31st.

Thank you for following @PennCardiology 🩺 Continue the conversation with us at @PennMedicine and @PennMDForum.

Penn Heart & Vascular @PennCardiology May 11

Arrhythmia care is now central to #cardiooncology. From AF & VT management to drug interactions and device decisions, this review highlights how to balance rhythm control with #cancer treatment in a complex, high-risk population.

spr.ly/6011BBProB

@dr_mike_fradley

www.heartrhythmjournal.com Arrhythmias and cardiac devices management in oncology patients Cardiac arrhythmia is increasingly encountered in patients with cancer, not only as a result of shared risk factors but also as a direct consequence of malignancy and its therapies. This evolving...

Penn Heart & Vascular @PennCardiology May 7

Atrial fibrillation in #HCM isn't just typical AF.

Atrial remodeling, fibrosis, & ion-channel changes drive a distinct disease w/ worse outcomes and lower rhythm control success. So, where do current therapies fall short & what comes next?

👉spr.ly/6016BBPrg0

@tikuowens

www.heartrhythmjournal.com Atrial fibrillation in hypertrophic cardiomyopathy: A unique clinical entity requiring dedicated... Atrial fibrillation (AF) is the most common sustained arrhythmia in hypertrophic cardiomyopathy (HCM) occurring in 20%–25% of patients and associated with significant morbidity including stroke risk...